Calcium Citrate Chewable Natural Mixed Fruit Flavor

product on market Tablet or Pill KAL 🟢 Safety: 100/100
Brand: KAL
🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 40% of ingredients have research evidence
A Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Chewable (s) Serving Size
30 Servings
Other Combinations Product Type
40% Evidence Coverage

Supplement Facts — Evidence Check

Calories
20 Calorie(s)
Total Carbohydrates
4 Gram(s) (1% DV)
200 IU (50% DV)
✅ Within RDA (0.3× RDA of 0.015 mg) 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.005mg UL 0.1mg
Calcium
500 mg (50% DV)
250 mg (63% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 250mg

Other Ingredients

Sorbitol Fructose Guar Gum Natural Flavors Stearic Acid Silica Citric Acid Malic Acid Orange juice concentrate Stevia Beet

Label Claims — Verification

❓ Nutrient
❓ All Other
❓ Structure/Function
All Other (100% of products) Structure/Function (81% of products) Nutrient (71% of products) Approved Health (13% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

2 daily

Directions: Use only as directed. Take 2 chewable tablets daily with a meal.

⚠️ Warnings & Precautions

Warning: Do not use if safety seal is broken or missing.

Keep out of reach of children.

Keep your licensed health care practitioner informed when using this product.

🧪 Formulation Notes

Natural mixed fruit flavor with Mag & D-3

Discussion: KAL Calcium Citrate Chewable, with natural mixed fruit flavor, provides a great-tasting way to take Calcium, Magnesium and Vitamin D-3.

Calcium is intended to provide nutritive support for normal, healthy bones and teeth, proper nerve impulse transmission and muscle contraction.

Magnesium and Vitamin D are intended to work synergistically with Calcium.

Additional Information

KAL Innovative quality since 1932

Store in a cool, dry place.

Product Details

UPC / SKU 0 21245 57200 8
DSLD Entry Date 2021-09-24
Product Type Other Combinations
Form Tablet or Pill
Brand KAL
DSLD ID 254633
Data Updated 2026-04-11

Research Evidence

511 Research Sources
57 Avg Quality Score
266 Meta Analysis
95 Systematic Review
76 Rct
49 Clinical Trial
12 Guideline
4 Regulatory Source
2 Cochrane Review
2 Other
2 Narrative Review
1 Openfda Safety
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
PubMed DOI Cochrane
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
PubMed DOI Cochrane
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
PubMed DOI Cochrane
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
PubMed DOI Cochrane
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
PubMed DOI Cochrane
A First-line drugs for hypertension
Meta Analysis The Cochrane database of systematic reviews 2018
PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
PubMed DOI Cochrane
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
PubMed DOI Cochrane
A Beta-blockers for hypertension
Meta Analysis The Cochrane database of systematic reviews 2017
PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
PubMed DOI
View all evidence for Calcium →

Compare Similar Products

Cipcal-500 Cipla 100
Calcium Citrate Plus Minerals New Sun 100
Calcium Citrate NOW 100
Calcium Citrate
Calcium Citrate NOW 100
Calcium Citrate with 500 mg of Calcium Kirkland Signature 100
View all Calcium products →
Calcium research & evidence Best Calcium rankings All Calcium products More from KAL View on NIH DSLD →